Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial

NCT00033917 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00033917
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00033917 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial
Lead sponsor
Yale University
Phase
Phase 3
Overall status
Completed
Start date
September 30, 1989
Completion date
March 31, 2012
Enrollment
630 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding in the brain, intraventricular hemorrhage (ivh), prematurity, very low birth weight infants